UnitedHealth Group (NYSE:UNH) Shares Down 2.2% – Time to Sell?

UnitedHealth Group Incorporated (NYSE:UNH) shares dropped 2.2% during trading on Monday . The company traded as low as $269.09 and last traded at $269.6150. Approximately 10,208,455 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 10,011,376 shares. The stock had previously closed at $275.59.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH is expanding AI investments to drive efficiency and margin improvement; management reiterated growth and operational-improvement priorities at conferences, which supports medium-term profitability. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Recent quarterly results showed a small EPS beat and revenue growth year-over-year; that underlying earnings strength and management’s reiterated guidance provide a constructive earnings foundation (supports analyst valuation).
• Neutral Sentiment: Wall Street analysts remain broadly bullish on UNH (average brokerage recommendation favors buying), which can prop up the stock, though the coverage is noted as often optimistic and may have limited immediate impact. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Industry hiring and AI-focused vendor moves (e.g., executive hiring at an AI-driven claims remediation firm) highlight sector innovation trends that could indirectly benefit large payor/Optum capabilities, but impact on UNH’s near-term stock trajectory is unclear. Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
• Negative Sentiment: The DOJ has intensified an antitrust probe into Optum and UnitedHealth’s integrated model; heightened regulatory scrutiny raises headline risk, potential remedies, and valuation uncertainty for UNH. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: A proposed settlement in an insulin pricing case would leave CVS Caremark settled while UnitedHealth remains the sole holdout, underscoring litigation and competitive risks that could lead to future costs or reputational impacts if UNH becomes a target. CVS, FTC reach proposed settlement in insulin pricing case

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Oppenheimer reduced their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Jefferies Financial Group reduced their price objective on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Weiss Ratings cut shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, March 2nd. Truist Financial lowered their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Price Performance

The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market cap of $245.51 billion, a price-to-earnings ratio of 20.51, a PEG ratio of 1.24 and a beta of 0.41. The company’s 50-day moving average price is $294.53 and its 200-day moving average price is $323.80.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.3%. UnitedHealth Group’s dividend payout ratio is 67.02%.

Institutional Trading of UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $25,000. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. Anfield Capital Management LLC increased its holdings in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.